Table 1.
Gene Expression values and Risk scores of samples of BLCA patients of our cohort.
| Tumor Samples | DLX1 | DSC1 | GNLY | Risk Score | Risk Group | 
|---|---|---|---|---|---|
| T37 | 0.395464 | 0.399748 | 0.398755 | 0.14094403 | Low Risk | 
| T15 | 0.409501 | 0.427576 | 0.421973 | 0.14751408 | Low Risk | 
| T9 | 0.42662 | 0.411521 | 0.409563 | 0.15173857 | Low Risk | 
| T44 | 0.423999 | 0.43461 | 0.405816 | 0.1585099 | Low Risk | 
| T50 | 0.47725 | 0.477138 | 0.441988 | 0.17880091 | Low Risk | 
| T10 | 0.417016 | 0.429026 | 0.310101 | 0.17956884 | High Risk | 
| T52 | 0.499292 | 0.488207 | 0.458136 | 0.18501026 | High Risk | 
| T39 | 0.480964 | 0.475889 | 0.416388 | 0.18633474 | High Risk | 
| T14 | 0.483882 | 0.495983 | 0.424441 | 0.19098316 | High Risk | 
| T42 | 0.501269 | 0.52213 | 0.442059 | 0.1996277 | High Risk |